Neuropsychiatric symptoms
Showing 1 - 25 of >10,000
Long Covid19, Neuropsychiatric Symptoms, Electro-acupuncture Trial in Kowloon Tong (Acupuncture, Sham-acupuncture)
Not yet recruiting
- Long Covid19
- +2 more
- Acupuncture
- Sham-acupuncture
-
Kowloon Tong, Kowloon, Hong KongZhong Lidan
Jun 1, 2023
Neuropsychiatric Symptoms in Spontaneous Intracerebral
Not yet recruiting
- Primary Disease or Condition Being Studied, or Focus of the Study
- neuropsychiatric symptoms
-
Taipei, TaiwanBei-Hu Branch, National Taiwan University Hospital
Nov 11, 2022
Post-COVID-19 Syndrome Trial in Geneva (Temelimab 54mg/kg, Placebo)
Not yet recruiting
- Post-COVID-19 Syndrome
- Temelimab 54mg/kg
- Placebo
-
Geneva, SwitzerlandGeneva University Hospital
Aug 9, 2022
Dementia Trial in Limoges, Toulouse (telemedicine)
Completed
- Dementia
- telemedicine
-
Limoges, France
- +1 more
Feb 28, 2022
EEG-characteristics of Neuropsychiatric Symptoms in Chronic Pain
Not yet recruiting
- Chronic Pain
- EEG / questionnaires / working memory task
-
München, Bavaria, GermanyDepartment of Neurology, Center for Interdisciplinary Pain Medic
Feb 18, 2022
Idiopathic Parkinson's Disease, Parkinson Disease, Depression Trial in Baltimore (Transcranial Direct Current Stimulation)
Recruiting
- Idiopathic Parkinson's Disease
- +2 more
- Transcranial Direct Current Stimulation
-
Baltimore, MarylandJohns Hopkins Hospital / Johns Hopkins University
Mar 28, 2022
A Music-Based Mobile App for People Living With Alzheimer's
Recruiting
- Dementia
- +2 more
- Feasibility study of music-based mobile app
-
Brooklyn, New YorkAutotune Me, LLC
Nov 21, 2023
Alzheimer, Mild Cognitive Impairment, Neuropsychiatric Symptoms Trial in Palo Alto (Cognitive Behavioral Therapy for Insomnia
Recruiting
- Alzheimer Disease
- +3 more
- Cognitive Behavioral Therapy for Insomnia (CBT-I)
- Desensitization Therapy for insomnia (DT-I)
-
Palo Alto, CaliforniaAndrea Goldstein-Piekarski, PhD
Sep 20, 2021
Dementia Trial (Clinician-facilitated educational intervention, Enhanced usual care)
Not yet recruiting
- Dementia
- Clinician-facilitated educational intervention
- Enhanced usual care
- (no location specified)
Apr 21, 2022
Alzheimer, Dementia, Mixed, Dementia Trial in Toronto (Transcranial Direct Current Stimulation (tDCS))
Recruiting
- Alzheimer Disease
- +4 more
- Transcranial Direct Current Stimulation (tDCS)
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Nov 12, 2021
Activity and Health in Nursing Homes
Active, not recruiting
- Old Age
- Frailty
- no intervention
-
Trondheim, NorwayTrondheim Kommune
Mar 29, 2022
TSC, Behavioral Symptoms Trial in Carrboro, Cincinnati (Behavioral Intervention in a small group platform)
Recruiting
- TSC
- Behavioral Symptoms
- Behavioral Intervention in a small group platform
-
Carrboro, North Carolina
- +1 more
Oct 23, 2023
Mild Cognitive Impairment Trial in Hong Kong (13-week multimodal intervention, 5-week health education programme)
Active, not recruiting
- Mild Cognitive Impairment
- 13-week multimodal intervention
- 5-week health education programme
-
Hong Kong, Hong Kong
- +1 more
Dec 12, 2021
Parkinson's Disease Trial in United States (Pimavanserin, Placebo, Quetiapine)
Mild Cognitive Impairment, Behavioral Symptoms Trial in Hong Kong (Face-to-face interviews)
Completed
- Mild Cognitive Impairment
- Behavioral Symptoms
- Face-to-face interviews
-
Hong Kong, Hong KongUniversity of Hong Kong
Jan 19, 2021
Autism Spectrum Disorder, Atopy Trial in Boston (Omalizumab Injection [Xolair])
Withdrawn
- Autism Spectrum Disorder
- Atopy
- Omalizumab Injection [Xolair]
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 11, 2021
Alzheimer's Disease, Alzheimer Dementia (AD), Aggression Trial in Canada (Non-Pharmacological Intervention, Pharmacological
Recruiting
- Alzheimer's Disease
- +2 more
- Non-Pharmacological Intervention
- Pharmacological Intervention
-
Calgary, Alberta, Canada
- +5 more
Mar 15, 2021
Dementia Trial in Ottestad (TIME, Education-only intervention)
Completed
- Dementia
- TIME
- Education-only intervention
-
Ottestad, NorwayThe Research centre for Age-related Functional decline and Disea
Sep 28, 2020
Neuroinflammation in COVID-19 and Depression
Recruiting
- Major Depressive Episode
- Covid19
- [18F]FEPPA PET scan
- [11C]SL25.1188 PET scan
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Apr 20, 2021
Psychosis, Negative Symptoms With Primary Psychotic Disorder Trial in Glostrup (Memantine, Placebo)
Recruiting
- Psychosis
- Negative Symptoms With Primary Psychotic Disorder
- Memantine
- Placebo
-
Glostrup, Capitol Region, DenmarkCentre for Neuropsychiatric Schizophrenia Research, CNSR & Centr
Aug 23, 2021
PANDAS, Anxiety Disorder, Autoimmune Diseases Trial in Boston (Naproxen Sodium, Placebo)
Recruiting
- PANDAS
- +3 more
- Naproxen Sodium
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Feb 14, 2022
Parkinson Disease, Fluctuating Mood Symptoms Trial in France (FN scale auto-questionnaire)
Recruiting
- Parkinson Disease
- Fluctuating Mood Symptoms
- FN scale auto-questionnaire
-
Amiens, France
- +5 more
Sep 27, 2021
PANS - A Detailed Study of Patients, Their Symptoms, Biomarkers
Completed
- Obsessive-compulsive Disorder With Acute Onset
- +5 more
-
Stockholm, Sverige, SwedenNorthern Stockholm psychiatry
Oct 21, 2020
Neuropsychiatric Symptoms Related to Neurodegenerative Disease Trial in Worldwide (Pimavanserin, Placebo)
Completed
- Neuropsychiatric Symptoms Related to Neurodegenerative Disease
- Pimavanserin
- Placebo
-
Gilbert, Arizona
- +103 more
Aug 12, 2022
Dementia; Alzheimer, Mixed Type (Etiology) Trial in Toronto (Transcranial Direct Current Stimulation)
Completed
- Dementia; Alzheimer, Mixed Type (Etiology)
- Transcranial Direct Current Stimulation
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jul 2, 2020